Compare IPSC & CDZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IPSC | CDZI |
|---|---|---|
| Founded | 2019 | 1983 |
| Country | United States | United States |
| Employees | N/A | 31 |
| Industry | Medicinal Chemicals and Botanical Products | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 413.0M | 413.8M |
| IPO Year | 2021 | N/A |
| Metric | IPSC | CDZI |
|---|---|---|
| Price | $2.31 | $4.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.25 | N/A |
| AVG Volume (30 Days) | ★ 739.4K | 710.5K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.30 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | $12.97 |
| Revenue Next Year | N/A | $102.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $2.58 |
| 52 Week High | $2.97 | $6.96 |
| Indicator | IPSC | CDZI |
|---|---|---|
| Relative Strength Index (RSI) | 50.25 | 34.74 |
| Support Level | $2.15 | $3.36 |
| Resistance Level | $2.67 | $5.10 |
| Average True Range (ATR) | 0.12 | 0.23 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 62.00 | 1.81 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, generating maximum revenue engaged in providing water filtration solutions for impaired or contaminated groundwater sources.